Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

PharmaGap reports results from animal studies of PhG-alpha1 for cancer

April 25, 2008

FDA approves Calando's IND application for siRNA nanoparticle therapeutic CALAA-01

April 24, 2008

AEterna Zentaris develops new cytotoxic conjugate, AEZS-125

April 24, 2008

MI-219 displays preclinical anticancer activity

April 24, 2008

Novel inhibitor of tyrosine kinases shows antitumor activity in preclinical models

April 24, 2008

Hsp90 inhibitors demonstrate antitumor effects in preclinical studies

April 24, 2008

Lorus Therapeutics to examine new administration route for LOR-2040

April 23, 2008

SNS-314 induces tumor growth inhibition in xenograft models

April 23, 2008

BMS-753493 cytotoxic in folate receptor-positive human tumor cells

April 23, 2008

Kosan demonstrates anticancer activity of CRM1-protein inhibition

April 23, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...